Search Results 281-290 of 15209 for TNF

1. A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

   ... TNF treatment, abatacept, alemtuzumab, IVIg, belimumab, tocilizumab, or eculizumab within 12 weeks prior to screening; For patients scheduled to receive ...

2. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Received CD20 inhibitor, anti-tumor necrosis factor treatment, abatacept, alemtuzumab, any other experimental or biological therapy, intravenous ...

3. Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010) - Mayo Clinic

   Prior therapy with an anti-programmed cell death (PD)-1, anti-PD-L1, anti-PD-L2, anti-tumor necrosis factor CD137, or anti-cytotoxic T-lymphocyte-associated ...

4. A Study to Evaluate the Effectiveness and Safety of Obeticholic Acid to Treat Patients with Primary Sclerosing Cholangitis - Mayo Clinic

   Subjects being administered biologic treatments (eg, anti-tumor necrosis factor (TNF) or anti-integrin monoclonal antibodies), immunosuppressants, systemic ...

5. Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Systemic Sclerosis - Mayo Clinic

   Tumor necrosis factor inhibitors within 12 weeks of screening; Leflunomide within 8 weeks of screening; Therapeutic pheresis within 4 weeks of Screening; Any ...

6. Publications - Regan N. Theiler, M.D., Ph.D. - Mayo Clinic

   Effect of Anti-TNF Biologic Exposure During Pregnancy on Villitis of Unknown Etiology Diagnoses in Patients with Autoimmune Disease. Reprod Sci. 2024 Apr ...

7. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

   Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

8. Publications - Andrew P. Norgan, M.D., Ph.D. - Mayo Clinic

   Effect of Anti-TNF Biologic Exposure During Pregnancy on Villitis of Unknown Etiology Diagnoses in Patients with Autoimmune Disease. Reprod Sci. 2024 Apr ...

9. A Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas - Mayo Clinic

   The purpose of this study is to evaluate children ≥ 1 year of age and adults with neurofibromatosis type 1 (NF1) and plexiform neurofibromas treated with the ...

10. FrαDcs Or Placebo For Patients With Advanced Stage Ovarian Cancer - Mayo Clinic

    ... tumor necrosis factor (TNF)-α agents) ≤ 2 weeks prior to registration, or anticipation of need for systemic immunosuppressive medication during the course ...